Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1960 1
1964 1
1972 1
1975 1
1979 17
1980 23
1981 38
1982 42
1983 55
1984 42
1985 64
1986 74
1987 82
1988 137
1989 108
1990 120
1991 154
1992 185
1993 244
1994 257
1995 283
1996 336
1997 356
1998 345
1999 428
2000 500
2001 654
2002 677
2003 838
2004 1008
2005 1177
2006 1474
2007 1658
2008 1991
2009 2238
2010 2718
2011 3373
2012 3860
2013 4625
2014 5364
2015 6063
2016 6411
2017 7006
2018 8415
2019 9812
2020 11912
2021 13977
2022 16906
2023 16920
2024 19940
2025 8915
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145,062 results

Results by year

Filters applied: . Clear all
Page 1
Mi-2β promotes immune evasion in melanoma by activating EZH2 methylation.
Li C, Wang Z, Yao L, Lin X, Jian Y, Li Y, Zhang J, Shao J, Tran PD, Hagman JR, Cao M, Cong Y, Li HY, Goding CR, Xu ZX, Liao X, Miao X, Cui R. Li C, et al. Among authors: wang z. Nat Commun. 2024 Mar 9;15(1):2163. doi: 10.1038/s41467-024-46422-5. Nat Commun. 2024. PMID: 38461299 Free PMC article.
Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial.
Zhou HQ, Zhang YX, Chen G, Yu QT, Zhang H, Wu GW, Wu D, Lin YC, Zhu JF, Chen JH, Hu XH, Lan B, Zhou ZQ, Lin HF, Wang ZB, Lei XL, Pan SM, Chen LM, Zhang J, Kong TD, Yao JC, Zheng X, Li F, Zhang L, Fang WF. Zhou HQ, et al. Among authors: wang zb. Signal Transduct Target Ther. 2024 Aug 13;9(1):215. doi: 10.1038/s41392-024-01927-9. Signal Transduct Target Ther. 2024. PMID: 39134529 Free PMC article. Clinical Trial.
Model-informed precision dosing: State of the art and future perspectives.
Minichmayr IK, Dreesen E, Centanni M, Wang Z, Hoffert Y, Friberg LE, Wicha SG. Minichmayr IK, et al. Among authors: wang z. Adv Drug Deliv Rev. 2024 Dec;215:115421. doi: 10.1016/j.addr.2024.115421. Epub 2024 Aug 17. Adv Drug Deliv Rev. 2024. PMID: 39159868 Free article. Review.
145,062 results
You have reached the last available page of results. Please see the User Guide for more information.